Dr. Michael Engel
I've won the following awards
Top Pediatric Hematologist and Oncologist, National
Top Doctor, Utah
Thought Leader, Utah
St. Baldricks Foundation Scholar
Ruth L. Kirschstein National Research Service Award, National Institutes of Health
ASPHO Young Investigator Award
Career Development Award, National Institutes of Health
Sunbeam Foundation Scholar
Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription.
The Journal of biological chemistry, 274, 37413-20 (1999)
Signal transduction by transforming growth factor-beta: a cooperative paradigm with extensive negative regulation.
Journal of cellular biochemistry. Supplement, 30-31, 111-22 (1998)
Interaction of the transforming growth factor-beta type I receptor with farnesyl-protein transferase-alpha.
The Journal of biological chemistry, 270, 29628-31 (1995)
RhoB is stabilized by transforming growth factor beta and antagonizes transcriptional activation.
The Journal of biological chemistry, 273, 9921-6 (1998)
Role of transforming growth factor (TGF)-beta Type I and TGF-beta type II receptors in the TGF-beta1-regulated gene expression in pituitary prolactin-secreting lactotropes.
Endocrinology, 139, 3620-8 (1998)
Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism.
Molecular biology of the cell, 12, 27-36 (2001)
Deletion of Mtg16, a target of t(16;21), alters hematopoietic progenitor cell proliferation and lineage allocation.
Molecular and cellular biology, 28, 6234-47 (2008)
Proleukemic RUNX1 and CBFbeta mutations in the pathogenesis of acute leukemia.
Cancer treatment and research, 145, 127-47 (2010)
Myeloid translocation gene 16 (MTG16) interacts with Notch transcription complex components to integrate Notch signaling in hematopoietic cell fate specification.
Molecular and cellular biology, 30, 1852-63 (2010)
Mtg16/Eto2 contributes to murine T-cell development.
Molecular and cellular biology, 31, 2544-51 (2011)
Kaiso directs the transcriptional corepressor MTG16 to the Kaiso binding site in target promoters.
PloS one, 7, e51205 (2012)
The enemy within: dormant retroviruses awaken.
Nature medicine, 16, 517-8 (2010)
Vincristine, irinotecan and temezolamide for treatment of relapsed alveolar rhabdomyosarcoma
J Pediatric Hematol Oncol, Volume 35(4), Page 163-166 (2013)
Neuroendocrine carcinoma in an adolescent with hypercortisolemia
J Pediatric Hematol Oncol, Volume 34(3), Page 117-119 (2012)